Clinical trials

  • LISOCABTAGENE MARALEUCEL for Follicular lymphoma | Marginal zone lymphoma | Relapsed or refractory indolent B-cell non-Hodgkin lymphoma
  • PREDNISONE for Granulomatosis with polyangiitis (Wegener's) | Microscopic polyangiitis | ANCA-associated vasculitis
  • PANITUMUMAB for Metastatic colorectal cancer
  • FUTIBATINIB for Advanced solid tumour | Malignant solid tumor
  • TUB-040 (active substance name as listed) for Platinum-resistant high-grade ovarian cancer|Relapsed/refractory adenocarcinoma non-small cell lung cancer
  • ALGLUCOSIDASE ALFA for Pompe disease
  • Adeno-associated virus vector containing the human RPGR gene for X-linked retinitis pigmentosa (XLRP)|Retinitis pigmentosa
  • NVL-655 for Non-small cell lung cancer (advanced) | ALK-positive solid tumors
  • AMG 193 for Gastrointestinal cancer | Biliary tract cancer | Pancreatic ductal adenocarcinoma with homozygous MTAP deletion
  • IFINATAMAB DERUXTECAN for Esophageal squamous cell carcinoma
  • KYV-101 for Lupus nephritis|Systemic sclerosis|Myasthenia gravis|Rheumatoid arthritis|Stiff-person syndrome
  • BEVACIZUMAB for Advanced hepatocellular carcinoma|Liver transplant recipient